Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

IDEC receives patent coverage for platform technology

Feb. 12, 1997

Merck & Co. and Costa Rican institute renew biological diversity agreement

Feb. 11, 1997

Genentech funds basic research related to human birth defects

Feb. 10, 1997

Vyrex gene discovery platform receives patent coverage

Feb. 10, 1997

Zynaxis sells drug delivery technology

Feb. 7, 1997

Abgenix reports significant advance in human antibody technology

Feb. 6, 1997

LifeTECH and Pall announce collaboration

Feb. 6, 1997

ICOS/Glaxo Wellcome collaboration modified

Feb. 4, 1997

Cytogen/Elan oral drug delivery collaboration advances

Feb. 4, 1997

Zeneca/Pharmacopeia collaboration signed

Jan. 31, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...